CN Patent

CN111285887B — 一种螺环化合物

Assigned to Shanghai Xinnuo Life Sustaining Pharmaceutical Co ltd · Expires 2020-11-17 · 5y expired

What this patent protects

本发明公开了一种螺环化合物、其用途及含其的药物组合物。该化合物的结构如式I所示，其对RET激酶的抑制效果较佳。

USPTO Abstract

本发明公开了一种螺环化合物、其用途及含其的药物组合物。该化合物的结构如式I所示，其对RET激酶的抑制效果较佳。

Drugs covered by this patent

Patent Metadata

Patent number
CN111285887B
Jurisdiction
CN
Classification
—
Expires
2020-11-17
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Xinnuo Life Sustaining Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.